Startups
It’s so much more than a specimen. It's a life.
With over 30 years of specialized expertise in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critical patients, Eurofins Viracor is committed to helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most.
Eurofins Viracor is passionate about providing timely, actionable test results, never losing sight of the connection between the testing we perform and the patients our results ultimately serve.
Find out more by visiting us at www.eurofins-viracor.com/clinical
Eurofins Viracor is an equal opportunity employer.
With over 30 years of specialized expertise in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critical patients, Eurofins Viracor is committed to helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most.
Eurofins Viracor is passionate about providing timely, actionable test results, never losing sight of the connection between the testing we perform and the patients our results ultimately serve.
Find out more by visiting us at www.eurofins-viracor.com/clinical
Eurofins Viracor is an equal opportunity employer.
Overview
Location
United States, Kansas, Lenexa
Employees
201-500
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 27, 2023 | Up to 450,000 in U.S. have red meat allergies due to alpha-gal syndrome spread by ticks, CDC says | Thousands more Americans are now testing positive each year for alpha-gal syndrome — a condition spread by tick bites that causes allergic reactions to eating red meat. New data released by the Centers for Disease Control and Prevention sho... |
| Mar 15, 2023 | Rare Event Analysis in Flow Cytometry: Design Control and Validation Aligned with CLSI H62, Upcoming Webinar Hosted by Xtalks | Flow cytometry is considered an ideal technology for the detection of rare populations of cells. TORONTO (PRWEB) March 15, 2023 Rare event analysis by flow cytometry is relatively common in research settings, in clinical laboratories and du... |
| Nov 17, 2022 | Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond, Upcoming Webinar Hosted by Xtalks | A case study is presented to link acceptable RT-qPCR validation performance with the efficacy of the Moderna Phase 3 COVID-19 vaccine. TORONTO (PRWEB) November 17, 2022 The challenges of developing and validating qPCR assays in vaccine and ... |
| Oct 26, 2022 | Next-Generation Sequencing Applications for Antiviral Drug Development & FDA Guidance for Data Submission, Upcoming Webinar Hosted by Xtalks | Gene variants can compromise virologic response and impact clinical outcomes. TORONTO (PRWEB) October 26, 2022 Accurate detection and monitoring of minority variants that confer drug and antiviral resistance is critical to therapeutic and v... |
Reviews 0
FAQ about Eurofins Viracor
What has the press written about Eurofins Viracor?
Parsers VC has collected 5 articles mentioning Eurofins Viracor, among them “Up to 450,000 in U.S. have red meat allergies due to alpha-gal syndrome spread by ticks, CDC says” (Jul 27, 2023) and “Rare Event Analysis in Flow Cytometry: Design Control and Validation Aligned with CLSI H62, Upcoming Webinar Hosted by Xtalks” (Mar 15, 2023).
Is Eurofins Viracor still active?
Yes, Eurofins Viracor is active; its latest activity on Parsers VC dates from Apr 15, 2024.